Novel EGR2 mutation R359Q is associated with CMT type 1 and progressive scoliosis

Suter, 2003, Disease mechanisms in inherited neuropathies, Nat Rev Neurosci, 4, 714, 10.1038/nrn1196 Warner, 1998, Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies, Nat Genet, 18, 382, 10.1038/ng0498-382 Joseph, 1988, Molecular cloning, sequencing, and mapping of EGR2, a human early growth response gene encoding a protein with ‘zinc-binding finger’ structure, Proc Natl Acad Sci USA, 85, 7164, 10.1073/pnas.85.19.7164 Topilko, 1994, Krox-20 controls myelination in the peripheral nervous system, Nature, 371, 796, 10.1038/371796a0 Seeman, 2000, Charcot-marie-tooth disease type 1A (CMT1A) and hereditary neuropathy with liability to pressure palsies (HNPP): reliable detection of the CMT1A duplication and HNPP deletion using 8 microsatellite markers in 2 multiplex PCRs, Int J Mol Med, 6, 421 Timmerman, 1999, Novel missense mutation in the early growth response 2 gene associated with Dejerine-Sottas syndrome phenotype, Neurology, 52, 1827, 10.1212/WNL.52.9.1827 Vandenberghe, 2002, Frequency of mutations in the early growth response 2 gene associated with peripheral demyelinating neuropathies, J Med Genet, 39, e81, 10.1136/jmg.39.12.e81 Choi, 2004, Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean charcot-marie-tooth neuropathy patients, Hum Mutat, 24, 185, 10.1002/humu.9261 Numakura, 2003, Screening of the early growth response 2 gene in Japanese patients with charcot-marie-tooth disease type 1, J Neurol Sci, 210, 61, 10.1016/S0022-510X(03)00028-5 Bellone, 1999, A novel mutation (D305V) in the early growth response 2 gene is associated with severe charcot-marie-tooth type 1 disease, Hum Mutat, 14, 353, 10.1002/(SICI)1098-1004(199910)14:4<353::AID-HUMU17>3.0.CO;2-4 Yoshihara, 2001, A novel missense mutation in the early growth response 2 gene associated with late-onset charcot-marie-tooth disease type 1, J Neurol Sci, 184, 149, 10.1016/S0022-510X(00)00504-9 Pareyson, 2000, Cranial nerve involvement in CMT disease type 1 due to early growth response 2 gene mutation, Neurology, 54, 1696, 10.1212/WNL.54.8.1696 Boerkoel, 2001, EGR2 mutation R359W causes a spectrum of Dejerine-Sottas neuropathy, Neurogenetics, 3, 153, 10.1007/s100480100107 Taroni, 1999, Mutations in the Schwann cell transcription factor EGR2/Krox20 in patients with severe hereditary demyelinating neuropathies, Neurology, 52, A258 Chung, 2005, Two missense mutations of EGR2 R359W and GJB1 V136A in a charcot-marie-tooth disease family, Neurogenetics, 10 Nardelli, 1991, Base sequence discrimination by zinc-finger DNA-binding domains, Nature, 349, 175, 10.1038/349175a0 Warner, 1999, Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies, Hum Mol Genet, 8, 1245, 10.1093/hmg/8.7.1245